Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2021-09-02 Regulatory Filings
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration
Regulatory Filings Classification · 100% confidence The document is a press release dated September 2, 2021, announcing a corporate development: Bristol Myers Squibb exercising an option related to a collaboration with Evotec, involving a drug candidate (EVT8683) and associated financial terms (option payment, milestones, royalties). It is not a full annual report (10-K), an interim report (IR), an earnings release (ER), or a transcript (CT). It details a specific business transaction and partnership milestone achievement. This type of announcement, which is a significant corporate event but doesn't fit the specific financial reporting codes (like 10-K, IR, ER, DIV, CAP), is best classified as a general Regulatory Filing or News Announcement. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for significant, non-standard corporate news disseminated via services like DGAP, especially when it concerns licensing and development progress, which is often disclosed via regulatory channels.
2021-09-02 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them'. It details the name of an executive (Dr. Mario Polywka), their position, the financial instrument (Share), and the nature and details of the transaction (Exercise against cash settlement linked to a Share Performance Plan). This content directly matches the definition for Director's Dealing.
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains sections detailing 'Details of the person discharging managerial responsibilities' (a director/member of the managing body) and 'Details of the transaction(s)', specifically noting the 'Purchase of shares by exercising stock options'. This content directly corresponds to the definition of Director's Dealing reports, which are classified under the code DIRS.
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'DGAP-DD: Evotec SE english' and contains the header 'Directors’ Dealings'. The content details transactions made by a 'person discharging managerial responsibilities' (Dr. Cord Dohrmann, Member of the managing body) regarding company shares, including the nature of the transaction ('Exercise against cash settlement (Share Performance Plan)') and the date. This directly corresponds to the definition of Director's Dealing.
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. Section 4 details the 'Nature of the transaction' as a 'Purchase of shares by exercising stock options' by a 'Member of the managing body' (Dr. Craig Johnstone). This content directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2021-09-01 English
DGAP-DD: Evotec SE english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information regarding transactions by a 'person discharging managerial responsibilities' (Dr. Craig Johnstone, Member of the managing body) in the company's shares. This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2021-09-01 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.